24th Apr 2008 12:04
Skyepharma PLC24 April 2008 SkyePharma PLC - Annual Information Update In accordance with the requirements of Prospectus Rule 5.2, the followinginformation and documents were published, or made available to the public, overthe 12 months from 23 April 2007 to 24 April 2008 (inclusive) in compliancewith laws and rules dealing with the regulation of securities, issuers ofsecurities and securities markets. This annual information update is required by, and is being made pursuant toProspectus Article 10 of the Prospectus Directive as implemented in the UK byProspectus Rule 5.2.3G made by the Financial Services Authority and not for anyother purpose and by filing this annual information update neither SkyePharmaPLC ('the Company'), nor any other person, takes any responsibility for, ormakes any representation, express or implied, as to the accuracy or completenessof, the information contained herein or referred to below. The informationcontained below or referred to below is not necessarily up to date as at thedate of this annual information update and the Company does not undertake anyobligation to update any such information in the future. Furthermore, suchinformation may have been prepared in accordance with the laws or regulations ofa particular jurisdiction and may not comply with or meet the relevant standardsof disclosure in any other jurisdiction. Neither this annual informationupdate, nor the information referred to below constitutes, by virtue of thiscommunication, an offer of any securities addressed to any person and should notbe relied on in such respect by any person. 1. Announcements via RNS The following UK regulatory announcements have been made via RNS a RegulatoryInformation Service and can be obtained from the London Stock Exchange websiteat www.londonstockexchange.com or the Company's website at www.skyepharma.com Date Announcement 23 Apr 2007 Regulatory Approval26 Apr 2007 Final Results1 May 2007 Re: UBS Conference1 May 2007 Further re Final Results3 May 2007 Director/PDMR Shareholding4 May 2007 Delist from NASDAQ4 May 2007 EGM Result4 May 2007 Director Shareholding14 May 2007 Research Update15 May 2007 Annual Information Update30 May 2007 Holding(s) in Company31 May 2007 Regulatory Approval31 May 2007 Share Purchase Plan6 June 2007 Holding(s) in Company14 June 2007 Healthcare Conference21 June 2007 Healthcare Conference26 June 2007 Re Agreement27 Jun 2007 Appointment29 Jun 2007 AGM Statement29 Jun 2007 Result of AGM3 Jul 2007 Re: Share Purchase Plan11 Jul 2007 Director/PDMR Holding12 Jul 2007 Director/PDMR Holding17 Jul 2007 AGM Resolutions2 Aug 2007 Share Purchase Plan6 Aug 2007 Research Update14 Aug 2007 Holding(s) in Company5 Sep 2007 Regulatory Approval6 Sep 2007 Share Purchase Plan6 Sep 2007 Notice of Results7 Sep 2007 Appointment of Adviser11 Sep 2007 Research Update19 Sep 2007 UBS Life Sciences Conference20 Sep 2007 Interim Results25 Sep 2007 Sachs Biotech Conference27 Sep 2007 Product Launch2 Oct 207 Re: Share Purchase Plan8 Oct 2007 Change of Marketing Partner9 Oct 2007 Non-Executive Chairman19 Oct 2007 Holding(s) in Company23 Oct 2007 Paxil Settlement29 Oct 2007 Holding(s) in Company2 Nov 2007 Research Update2 Nov 2007 Director/PDMR Holding5 Nov 2007 Product Update13 Nov 2007 Director Declaration19 Nov 2007 Holding(s) in Company20 Nov 2007 Piper Jaffray Conference23 Nov 2007 Holding(s) in Company27 Nov 2007 Holding(s) in Company29 Nov 2007 Board Change5 Dec 2007 Share Purchase Plan10 Dec 2007 Regulatory Application Update11 Dec 2007 Holding(s) in Company18 Dec 2007 Research Update18 Dec 2007 Director Declaration20 Dec 2007 Re Agreement2 Jan 2008 Share Purchase Plan3 Jan 2008 Regulatory Approval10 Jan 2008 Holding(s) in Company1 Feb 2008 Holding(s) in Company1 Feb 2008 Share Purchase Plan4 Feb 2008 Director Declaration5 Feb 2008 Research Update8 Feb 2008 Re Agreement21 Feb 2008 Notice of Results3 Mar 2008 Director/PDMR Shareholding10 Mar 2008 Holding(s) in Company12 Mar 2008 Holding(s) in Company27 Mar 2008 Board Change27 Mar 2008 Final Results3 Apr 2008 Share Purchase Plan15 Apr 2008 Research Update21 Apr 2008 Annual Report and Accounts22 Apr 2008 Re Agreement22 Apr 2008 Holding(s) in Company 2. Documents filed at Companies House All of the documents listed below were filed with the Registrar of Companies inEngland and Wales on or around the dates indicated. Copies of the documentsfiled with the Registrar of Companies can be obtained from Companies House(www.companieshouse.gov.uk) Date of Filing Brief Description of document(s) filed 29/05/2007 RES 13 EGM Resolutions13/06/2007 403a Declaration of Satisfaction of Mortgage/Charge18/07/2007 AA Annual Report and Accounts20/07/2007 288a Appointment of Director20/07/2007 RES 11/13 AGM Resolutions20/07/2007 123 Increase in Nominal Capital19/10/2007 288a Appointment of Director01/12/2007 288b Resignation of Director11/12/2007 88(2) Allotment of Shares18/01/2008 363 Annual Return 3. Documents published or sent to Shareholders or filed with the UK ListingAuthority viewing facility at: Financial Services AuthorityThe North ColonnadeCanary WharfLondonE14 5HS Date Document 25 May 2007 Annual Report (inc Notice of Meeting)17 Jul 2007 AGM Resolutions8 Oct 2007 Interim Report21 Apr 2008 Annual Report21 Apr 2008 Notice of Meeting21 Apr 2008 Form of Proxy21 Apr 2008 Amended Articles of Association Copies of the above reports can be obtained from the Company Secretary at: 105 PiccadillyLondonW1J 7NJ Name of contact and telephone number for queries: John MurphyCompany SecretarySkyePharma PLCTel: 020 7491 1777 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L